On Mar. 5, 2020, Hologic announced a molecular assay for detecting the novel coronavirus SARS-CoV-2 (previously 2019-nCoV) on the automated Panther Fusion system  developed by investigators at Hannover Medical School in Germany. The preclinical assay was described online in the Journal of Clinical Virology.